Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

10.62
-0.1600-1.48%
Post-market: 10.620.00000.00%19:30 EDT
Volume:126.31K
Turnover:1.35M
Market Cap:372.41M
PE:-88.50
High:10.88
Open:10.78
Low:10.59
Close:10.78
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:0.64
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:8.77
PE(LYR):-31.16

Loading ...

Piper Sandler Remains a Buy on Fennec Pharmaceuticals (FENC)

TIPRANKS
·
Apr 23

Far Eastern New Century Perluas Pendidikan Ekonomi Kitaran Seluruh Dunia Majukan Impak Kelestarian

prnewswire
·
Apr 23

Far Eastern New Century Expands Circular Economy Education Worldwide to Advance Sustainability Impact

prnewswire
·
Apr 22

Fennec says four PEDMARK studies accepted for presentation at ASCO annual meeting

Reuters
·
Apr 22

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Apr 22

Fennec Pharmaceuticals Price Target Maintained With a $13.00/Share by Wedbush

Dow Jones
·
Apr 16

Fennec Pharmaceuticals (FENC) Receives a Buy from Wedbush

TIPRANKS
·
Apr 16

BUZZ-Fennec up on study testing expanded use of its hearing‑loss prevention drug in cancer patients

Reuters
·
Apr 07

Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

GlobeNewswire
·
Apr 07

Fennec Pharmaceuticals director Rosty Raykov disposes common shares worth $0.1 million

Reuters
·
Apr 03

Fennec grants 377,500 inducement stock options to 24 new employees under equity plan

Reuters
·
Apr 01

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Mar 31

Fennec Pharmaceuticals (FENC) Gets a Buy from Wedbush

TIPRANKS
·
Mar 25

Piper Sandler Sticks to Their Buy Rating for Fennec Pharmaceuticals (FENC)

TIPRANKS
·
Mar 25

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Mar 24

Fennec Pharmaceuticals Q4 GAAP EPS $(0.17) Misses $0.04 Estimate, Sales $13.777M Miss $13.993M Estimate

Benzinga Earnings
·
Mar 24

Fennec Pharma FY product sales rise 50% to record high on PEDMARK adoption

Reuters
·
Mar 24

Fennec Q4 2025 net product sales rose 75% to USD 14 million as net loss widened to USD 5 million

Reuters
·
Mar 24

Fennec Pharmaceuticals Inc - Q4 2025 Net Product Sales $13.8 Mln

THOMSON REUTERS
·
Mar 24

Fennec Pharmaceuticals FY Product Sales USD 44.6 Million

THOMSON REUTERS
·
Mar 24